{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:01:52Z","timestamp":1791313312364,"version":"4.3.1"},"reference-count":16,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,8]],"date-time":"2017-03-08T00:00:00Z","timestamp":1488931200000},"content-version":"vor","delay-in-days":372,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.jacc.2015.12.046","type":"journal-article","created":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T14:15:49Z","timestamp":1456755349000},"page":"1062-1069","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"title":["Use of Guideline-Directed Medications\u00a0for\u00a0Heart Failure Before Cardioverter-Defibrillator Implantation"],"prefix":"10.1016","volume":"67","author":[{"given":"Gregory A.","family":"Roth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne E.","family":"Poole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Zaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy E.","family":"Morden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2015.12.046_bib1","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure","volume":"352","author":"Bardy","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.046_bib2","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1056\/NEJMoa013474","article-title":"Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction","volume":"346","author":"Moss","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.046_bib3","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"Epstein","year":"2008","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.046_bib4","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.cardfail.2010.04.004","article-title":"HFSA 2010 comprehensive heart failure practice guideline","volume":"16","author":"Lindenfeld","year":"2010","journal-title":"J\u00a0Card Fail"},{"key":"10.1016\/j.jacc.2015.12.046_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jacc.2008.11.013","volume":"53","author":"Hunt","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2015.12.046_bib6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1067\/mhj.2001.115584","article-title":"Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta-analysis","volume":"141","author":"Packer","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2015.12.046_bib7","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.amjcard.2011.10.033","article-title":"How can optimization of medical treatment avoid unnecessary implantable cardioverter-defibrillator implantations in patients with idiopathic dilated cardiomyopathy presenting with \u201cSCD-HeFT criteria?\u201d","volume":"109","author":"Zecchin","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2015.12.046_bib8","unstructured":"Bonito A, Bann C, Eicheldinger C, Carpenter L. Creation of new race-ethnicity codes and socioeconomic status (SES) indicators for Medicare beneficiaries, Agency for Healthcare Research and Quality. Rockville, MD. August 2012. Available at: http:\/\/archive.ahrq.gov\/research\/findings\/final-reports\/medicareindicators\/index.html. Accessed February 27,\u00a02015."},{"key":"10.1016\/j.jacc.2015.12.046_bib9","series-title":"The Dartmouth Atlas of Health Care","year":"1996"},{"key":"10.1016\/j.jacc.2015.12.046_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ahj.2014.12.013","article-title":"A\u00a0validated risk model for one-year mortality after primary prevention implantable cardioverter defibrillator placement","volume":"170","author":"Heidenreich","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2015.12.046_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.2012.157182","article-title":"Survival of patients receiving a primary prevention implantable cardioverter-defibrillator in clinical practice vs clinical trials","volume":"309","author":"Al-Khatib","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2015.12.046_bib12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa043399","article-title":"Amiodarone or an implantable cardioverter\u2013defibrillator for congestive heart failure","volume":"352","author":"Brady","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2015.12.046_bib13","first-page":"64","article-title":"Optimal medical therapy use among patients receiving implantable cardioverter\/defibrillators: insights from the National Cardiovascular Data Registry","volume":"172","author":"Miller","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2015.12.046_bib14","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1161\/CIRCOUTCOMES.109.880450","article-title":"Underutilization of beta-blockers in patients undergoing implantable cardioverter-defibrillator and cardiac resynchronization procedures","volume":"3","author":"Hauptman","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2015.12.046_bib15","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1161\/CIRCOUTCOMES.112.965368","article-title":"Longitudinal study of implantable cardioverter-defibrillators: methods and clinical characteristics of patients receiving implantable cardioverter-defibrillators for primary prevention in contemporary practice","volume":"5","author":"Masoudi","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jacc.2015.12.046_bib16","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1161\/CIRCULATIONAHA.108.824151","article-title":"Statin adherence and risk of accidents: a cautionary tale","volume":"119","author":"Dormuth","year":"2009","journal-title":"Circulation"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971600125X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S073510971600125X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T23:41:46Z","timestamp":1567640506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S073510971600125X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":16,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S073510971600125X"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2015.12.046","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726197944.793531473","asserted-by":"object"}]},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of Guideline-Directed Medications\u00a0for\u00a0Heart Failure Before Cardioverter-Defibrillator Implantation","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2015.12.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}